Mizuho’s Katz sees 'fertile' conditions driving robust M&A market into 2026 FILE PHOTO: The Reuters NEXT conference, in New York City · Reuters Sabrina Valle Wed, 3 December 2025 at 9:56 pm GMT+2 2 min read
In this article: EA
By Sabrina Valle
NEW YOR... See more
By Sabrina Valle and Maggie Fick
NEW YORK/LONDON (Reuters) -When Novo Nordisk CEO Mike Doustdar learned in late September that Metsera had accepted a $7.3 billion rival bid from Pfizer, he was not ready to give up just yet on the company and its portfolio... See more
